OXON Epidemiology
Shubhankar Joshi is a Senior Software Engineer at intelliCard Solutions AG, where responsibilities include PKI Certificate Lifecycle Management software development and smartcard validation software development using a range of programming languages and frameworks. Previous experience includes software engineering internships involving RFID smart card programming and NFC reader application development. Shubhankar has held multiple leadership roles within IAESTE, including Board Member, Finance at LC Zurich, and Head of Incoming at IAESTE India LC Manipal, focusing on accounting, workshop organization, and team leadership. Internships at Bharat Electronics and Hochschule Merseburg provided experience in full stack development and research in network architecture. Educational credentials include a Master of Science in Informatics from the University of Zurich and a Bachelor of Technology in Computer and Communication Engineering from Manipal Institute of Technology.
This person is not in the org chart
This person is not in any offices
OXON Epidemiology
OXON Epidemiology is a European full-service Contract Research Organization (CRO) specialising in the generation of Real-World Evidence (RWE) via primary data collection, secondary data and hybrid observational studies, pragmatic trials, synthesis research, and data analysis and modelling of drugs and devices in all major therapeutic areas. OXON strives to be the Go-To leader in the design and implementation of outstanding observational studies. Our mission is to integrate methodological and statistical thinking and insights to maximize value and provide solutions for our clients. As a leader CRO, OXON provides a unique blend of quality science and operational experience to support pharmaceutical and medical devices companies worldwide to obtain high-quality RWE for Safety, Market Access, and Clinical Development for improving patients’ and public health: • Multi-country field, chart review and database epidemiological studies • Patient registries • Pragmatic Trials • Systematic Reviews & Meta-analysis • PASS and PAES studies • Risk minimisation studies • Risk management • Statistical signal detection & analysis • Quantitative benefit-risk analysis for CTD / PBRER • Patient reported outcomes • Health economics & modelling • Meta-analysis and Evidence strategy